The 2023 VEITHsymposium On-Demand Library contains close to 1300 captured presentations from this year's conference and showcases presenter video and audio along with synchronous full motion slide content.
Listed below are highlights of many excellent presentations from this year's event:
With Acute Type B Aortic Intramural Hematomas (IMHs): When Is TEVAR Indicated: How Long Should Treatment Be Delayed For Optimal Outcomes: Earlier TEVAR Has More Adverse Events
Duration: 4 Minutes 44 Seconds
Presenter(s): Jean M. Panneton, MD
Date: 11/14/23 11:48 AM
Room: Grand Ballroom East
VEITH Session #: Session #4
VEITH Session Name: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
Value Of IVUS In Treating Complex Aortic Pathology
Duration: 4 Minutes 54 Seconds
Presenter(s): Andres Schanzer, MD
Date: 11/14/23 3:28 PM
Room: Grand Ballroom East
VEITH Session #: Session #6
VEITH Session Name: MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON THE UK NICE AAA GUIDELINES AND OTHER AORTIC PATHOLOGY
Endovascular And Surgical Venous Arterialization For REAL No Option Patients Facing Amputation From CLTI: Does Neo-Angiogenesis Occur
Duration: 5 Minutes 46 Seconds
Presenter(s): Roberto Ferraresi, MD
Date: 11/15/23 2:23 PM
Room: Grand Ballroom East
VEITH Session #: Session #27
VEITH Session Name: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Single, Double Or 3-Branched Endograft Devices For Arch Lesion Repairs: When Is Each Best And Why: How To Do It From A Totally Femoral Approach
Duration: 4 Minutes 43 Seconds
Presenter(s): Gustavo S. Oderich, MD, FACS
Date: 11/15/23 8:35 AM
Room: Trianon Ballroom
VEITH Session #: Session #40
VEITH Session Name: MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
Value Of Parallel Endografts In The Management Of TAAAs And Other Aorto-Iliac Pathology: Why Do They Fail And How To Make Them Work
Duration: 4 Minutes 55 Seconds
Presenter(s): David J. Minion, MD
Date: 11/16/23 8:24 AM
Room: Grand Ballroom East
VEITH Session #: Session #48
VEITH Session Name: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
DEBATE: TCAR Is Better Than TFCAS And Brachial/Radial Access For CAS
Duration: 4 Minutes 51 Seconds
Presenter(s): Marc L. Schermerhorn, MD, Mahmoud B. Malas, MD, MHS
Date: 11/17/23 8:47 AM
Room: Grand Ballroom East
VEITH Session #: Session #80
VEITH Session Name: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
DEBATE: Not So: TCAR Is No Better And Is More Costly Than TFCAS And Brachial/Radial Access CAS If One Has Appropriate Skills
Duration: 5 Minutes 23 Seconds
Presenter(s): D. Christopher Metzger, MD, William A. Gray, MD
Date: 11/17/23 8:53 AM
Room: Grand Ballroom East
VEITH Session #: Session #80
VEITH Session Name: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Update On The MicroNet-Covered Stents (C-Guard From InspireMD) For CAS: Value Overall, With High-Risk Lesions And With TCAR: Are There Any Downsides
Duration: 6 Minutes 28 Seconds
Presenter(s): Stefan Mueller-Huelsbeck, MD Piotr Musialek, MD, DPhil
Date: 11/17/23 7:59 AM
Room: Grand Ballroom East
VEITH Session #: Session #80
VEITH Session Name: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
|
